Article Text
Abstract
In this response article, we challenge a core assumption that lies at the centre of a round table discussion regarding the Pharmacogenetics to Avoid Loss of Hearing trial. The round table regards a genetic test for a variant (mt.1555A>G) that increases the risk of deafness if a carrier is given the antibiotic gentamicin. The idea is that rapid testing can identify neonates at risk, providing an opportunity to prevent giving an antibiotic that might cause deafness. We challenge the assumption that a positive test unequivocally guides antibiotic choice because, aside from the risk of deafness, all antibiotics for neonatal sepsis are equivalent. We argue that this assumption is faulty and has particularly troubling moral consequences. We claim that giving an alternative to gentamicin is potentially providing inferior treatment and thereby may increase the risk of death. Parents and doctors are faced with a terrible choice as a result of positive point-of-care testing (POCT): give gold-standard treatment and risk deafness or give second line care and risk death. While we do not indicate an answer to this choice, what we do argue is that such a deep and difficult choice is one that may make parents wish genetic testing was never undertaken, and therefore, contra some authors in the round table, provides a reason to gain specific consent for POCT.
- genethics
- genetic counselling/prenatal diagnosis
- minors/parental consent
- neonatology
Statistics from Altmetric.com
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Using a biomarker acutely to identify babies at risk of serious adverse effects from antibiotics: where is the ‘Terrible Moral and Medical Dilemma’?
- Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial
- Using biomarkers in acute medicine to prevent hearing loss: should this require specific consent?
- Genetic testing in the acute setting: a round table discussion
- Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO's currently recommended antibiotics—systematic review and meta-analysis
- Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey
- Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance
- Late-onset neonatal sepsis: recent developments
- Multidrug resistant neonatal sepsis in Peshawar, Pakistan
- Cumulative risk factors contributing to hearing loss in preterm infants